Sofinnova Investments, Inc. Biogen Inc. Transaction History

Sofinnova Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $34 Million - $38.8 Million	132,600 New	132,600 $36.9 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $7.44 Million - $9.56 Million	-33,220 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $21.9 Million - $28.6 Million	-77,380 Reduced 69.96%	33,220 $9.4 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $28.6 Million - $45.9 Million	110,600 New	110,600 $38.3 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $13.6 Million - $18 Million	-52,628 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $2.98 Million - $3.78 Million	-11,083 Reduced 17.4%	52,628 $16.7 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $14 Million - $19.4 Million	63,711 New	63,711 $18.9 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.